Special: Buy These 3 Cryptos to Beat Bitcoin

SCORE

44

INO: INOVIO PHARMACEUTICALS is a Sell


The current rating for INO is 44, which is 14% below its historic median rating of 50. This indicates higher risk than normal.


The rating is currently showing a lower than normal reading, suggesting risk levels could be higher than normal and additional caution is advised.